Literature DB >> 22779205

Evidence-based clinical recommendations regarding screening for oral squamous cell carcinomas.

Michael P Rethman1, William Carpenter, Ezra E W Cohen, Joel Epstein, Caswell A Evans, Catherine M Flaitz, Frank J Graham, Philippe P Hujoel, John R Kalmar, Wayne M Koch, Paul M Lambert, Mark W Lingen, Bert W Oettmeier, Lauren L Patton, David Perkins, Britt C Reid, James J Sciubba, Scott L Tomar, Alfred D Wyatt, Krishna Aravamudhan, Julie Frantsve-Hawley, Jennifer L Cleveland, Daniel M Meyer.   

Abstract

BACKGROUND: This article presents evidence-based clinical recommendations developed by a panel convened by the American Dental Association Council on Scientific Affairs. This report addresses the potential benefits and potential risks of screening for oral squamous cell carcinomas and the use of adjunctive screening aids to visualize and detect potentially malignant and malignant oral lesions. TYPES OF STUDIES REVIEWED: The panel members conducted a systematic search of MEDLINE, identifying 332 systematic reviews and 1,499 recent clinical studies. They selected 5 systematic reviews and 4 clinical studies to use as a basis for developing recommendations.
RESULTS: The panel concluded that screening by means of visual and tactile examination to detect potentially malignant and malignant lesions may result in detection of oral cancers at early stages of development, but that there is insufficient evidence to determine if screening alters disease-specific mortality in asymptomatic people seeking dental care. CLINICAL IMPLICATIONS: The panel suggested that clinicians remain alert for signs of potentially malignant lesions or early-stage cancers while performing routine visual and tactile examinations in all patients, but particularly in those who use tobacco or who consume alcohol heavily. Additional research regarding oral cancer screening and the use of adjuncts is needed.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22779205

Source DB:  PubMed          Journal:  Tex Dent J        ISSN: 0040-4284


  7 in total

Review 1.  Human Papillomavirus Laboratory Testing: the Changing Paradigm.

Authors:  Eileen M Burd
Journal:  Clin Microbiol Rev       Date:  2016-04       Impact factor: 26.132

2.  Evaluation of a biomarker based blood test for monitoring surgical resection of oral squamous cell carcinomas.

Authors:  Martin Grimm; Wiebke Kraut; Sebastian Hoefert; Michael Krimmel; Thorsten Biegner; Peter Teriete; Marcel Cetindis; Joachim Polligkeit; Susanne Kluba; Adelheid Munz; Siegmar Reinert
Journal:  Clin Oral Investig       Date:  2015-07-08       Impact factor: 3.573

3.  Monitoring carcinogenesis in a case of oral squamous cell carcinoma using a panel of new metabolic blood biomarkers as liquid biopsies.

Authors:  Martin Grimm; Sebastian Hoefert; Michael Krimmel; Thorsten Biegner; Oliver Feyen; Peter Teriete; Siegmar Reinert
Journal:  Oral Maxillofac Surg       Date:  2016-02-13

4.  (S)-N'-Nitrosonornicotine, a constituent of smokeless tobacco, is a powerful oral cavity carcinogen in rats.

Authors:  Silvia Balbo; Sandra James-Yi; Charles S Johnson; Michael G O'Sullivan; Irina Stepanov; Mingyao Wang; Dipankar Bandyopadhyay; Fekadu Kassie; Steven Carmella; Pramod Upadhyaya; Stephen S Hecht
Journal:  Carcinogenesis       Date:  2013-05-13       Impact factor: 4.944

5.  Study of functional infrared imaging for early detection of mucositis in locally advanced head and neck cancer treated with chemoradiotherapy.

Authors:  Ezra E W Cohen; Omar Ahmed; Masha Kocherginsky; Galyna Shustakova; Emily Kistner-Griffin; Joseph K Salama; Volodymyr Yefremenko; Valentyn Novosad
Journal:  Oral Oncol       Date:  2013-08-27       Impact factor: 5.337

6.  Different levels in alcohol and tobacco consumption in head and neck cancer patients from 1957 to 2013.

Authors:  Yu Zhang; Ruixia Wang; Limin Miao; Longbiao Zhu; Hongbing Jiang; Hua Yuan
Journal:  PLoS One       Date:  2015-04-13       Impact factor: 3.240

Review 7.  Redirecting the focus of cancer immunotherapy to premalignant conditions.

Authors:  M Rita I Young
Journal:  Cancer Lett       Date:  2017-01-24       Impact factor: 8.679

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.